97 Results for "

Ra Inhibitors

" in MedChemExpress (MCE) Product Catalog:
Products (97)

97 Results for "Ra Inhibitors" in MCE Product Catalog:

29
29 Publications Verification
Cat. No.: HY-N0142
CAS No.: 60-82-2
Synonyms: NSC 407292; RJC 02792
Phloretin (NSC 407292; RJC 02792) is a flavonoid extracted from Malus pumila Mill.,has anti-inflammatory activities. Phloridzin is a specific,competitive and orally active inhibitor of sodium/glucose cotransporters in the intestine (SGLT1) and kidney (SGLT2). Phloretin inhibits Yeast-made GLUT1 as well as Human erythrocyte GLUT1 with IC50values of 49 μM and 61 μM,respectively .Phloretin has the potential for the treatment of rheumatoid arthritis (RA) and allergic airway inflammation .
loading...
    loading...
22
22 Cited Publications
Cat. No.: HY-14531
CAS No.: 201410-53-9
Purity:  99.61%
Synonyms: R115866
Research Areas:  

Inflammation/Immunology

Talarozole (R115866) is an oral systemic all-trans retinoic acid metabolism blocking agent (RAMBA) which increases intracellular levels of endogenous all-trans retinoic acid (RA). Talarozole inhibits both CYP26A1 and CYP26B1 with IC50s of 5.4 and 0.46 nM, respectively.
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-15898
CAS No.: 288250-47-5
Purity:  99.03%
Y-320 is a potent, orally active phenylpyrazoleanilide immunomodulator. Y-320 inhibits IL-17 production by CD4 T cells stimulated with IL-15 with IC50 values of 20 to 60 nM. Y-320 enhances TP53, DMD, and COL17A1 PTC readthrough by G418 and increases cellular protein levels and protein synthesis. Y-320 concomitants use of with a low dose of Paclitaxel (HY-B0015) significantly sensitized multidrug resistance (MDR) tumors by inducing G2/M phase arrest and apoptosis. Y-320 can be used for research of rheumatoid arthritis (RA) and cancer .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-10291
CAS No.: 51543-40-9
Purity:  99.58%
Synonyms: (R)-Flurbiprofen; MPC7869
Tarenflurbil ((R)-Flurbiprofen) is the R-enantiomer of the racemate NSAID Flurbiprofen, Tarenflurbil ((R)-Flurbiprofen) inhibits the binding of [ 3H]9-cis-RA to RXRα LBD with IC50 of 75 μM. Tarenflurbil can be used for Alzheimer's disease research.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-100739
CAS No.: 1617495-03-0
Purity:  99.04%
Target:  

Proteasome

Research Areas:  

Cancer

RA190, a bis-benzylidine piperidon, inhibits proteasome function by covalently binding to cysteine 88 of ubiquitin receptor RPN13.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-18099A
CAS No.: 1265917-14-3
Synonyms: E-52862 hydrochloride
Research Areas:  

Neurological Disease

S1RA (E-52862) hydrochloride is an orally active and selective sigma-1 receptor (σ1R) antagonist with a Ki value of 17 nM. S1RA hydrochloride shows good selectivity against σ2R (Ki >1000 nM). S1RA hydrochloride is a human 5-HT2B receptor antagonist with an IC50 value of 4.7 μM. S1RA hydrochloride inhibits neuropathic pain and activity-induced spinal sensitization .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-147141
CAS No.: 2767422-72-8
Purity:  98.93%
HS-276 is an orally active, potent and highly selective TAK1 inhibitor, with a Ki of 2.5 nM. HS-276 shows significant inhibition of TAK1, CLK2, GCK, ULK2, MAP4K5, IRAK1, NUAK, CSNK1G2, CAMKKβ-1, and MLK1, with IC50 values of 8.25, 29, 33, 63, 125, 264, 270, 810, 1280, and 5585 nM, respectively. HS-276 reduces the expression of TNF, IL-6, and IL-1β. HS-276 can be used for rheumatoid arthritis (RA) research .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P10136
Synonyms: human TREM-2 182-190
Target:  

TREM receptor

Research Areas:  

Inflammation/Immunology

IA9 (human TREM-2 182-190) is a potent, CNS-penetrant TREM-2 inhibitor. IA9 can diminish the release of proinflammatory cytokines and suppress joint inflammation and damage in a Collagen (HY-P5003)-induced arthritis (CIA) mouse model. IA9 can be used for neuroinflammation PET imaging. IA9 can be used for Rheumatoid arthritis (RA) and neuroinflammation research .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-111532
CAS No.: 1359752-95-6
Purity:  99.73%
Target:  

ClpP Bacterial

Research Areas:  

Infection

(3R,4R)-A2-32-01 (compound 24(R,R)), the (R,R)-enantiomer of A2-32-01, is a Staphylococcus aureus caseinolytic protease (SaClpP) inhibitor .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-118530
CAS No.: 65002-17-7
Purity:  98.87%
Synonyms: SA96; Thiobutarit
Target:  

VEGFR

Bucillamine (SA96) is an orally active and potent sulfhydryl donor and antioxidant. Bucillamine is also an antirheumatic agent with antiangiogenic properties. Bucillamine can protect against Ischemia/reperfusion (I/R) injury in high-risk organ transplants. Bucillamine inhibits the production of VEGF. Bucillamine can be used for the research of choroidal neovascularization (CNV) and rheumatoid arthritis (RA) .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P10136A
Synonyms: human TREM-2 182-190 TFA
Target:  

TREM receptor

Research Areas:  

Inflammation/Immunology

IA9 TFA (human TREM-2 182-190 TFA) is a potent, CNS-penetrant TREM-2 inhibitor. IA9 TFA can diminish the release of proinflammatory cytokines and suppress joint inflammation and damage in a Collagen (HY-P5003)-induced arthritis (CIA) mouse model. IA9 TFA can be used for neuroinflammation PET imaging. IA9 TFA can be used for Rheumatoid arthritis (RA) and neuroinflammation research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-125099A
Purity:  99.83%
AFM-30a hydrochloride is a potent protein arginine deiminase 2 (PAD2) inhibitor and has excellent PAD2-selectivity. AFM-30a hydrochloride binds to PAD2 with an EC50 value of 9.5 μM. AFM-30a hydrochloride also inhibits H3 citrullination with an EC50 value of 0.4 μM. AFM-30a hydrochloride can be used for the research of certain cancers and a variety of autoimmune diseases including rheumatoid arthritis (RA), multiple sclerosis, lupus, and ulcerative colitis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-108522
CAS No.: 457657-34-0
Purity:  98.48%
Target:  

RAR/RXR

Research Areas:  

Metabolic Disease

PA452, retinoic X receptor (RXR) specific antagonist, inhibits the effect of Retinoic acid (RA) on Th1/Th2 development .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15427
CAS No.: 1133432-49-1
Purity:  98.05%
Target:  

Btk

Research Areas:  

Inflammation/Immunology Cancer

GDC-0834 is an orally active selective, potent, and reversible BTK inhibitor with an IC50 of 5.9 nM. GDC-0834 demonstrates pBTK-Tyr223 inhibition in mice and rats. GDC-0834 can be used for research of rheumatoid arthritis (RA) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P10284
CAS No.: 853248-13-2
S7 is an inhibitory polypeptide targeting IL-6R, which specifically binds to IL-6R and its A chain (gp80/IL-6RA) to block its signal transduction. S7 inhibits IL-6-mediated anti-apoptosis (apoptosis), angiogenesis and the expression of VEGF-A, blocks related survival signaling pathways, and enhances the sensitivity of cancer cells to chemotherapeutic drugs. S7 can be applied to the research of related diseases such as cervical cancer, multiple myeloma, Kaposi's sarcoma, prostate cancer and basal cell carcinoma .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P10935A
Synonyms: 5-MP TFA
Research Areas:  

Inflammation/Immunology

Amilo-5MER (5-MP) TFA is an orally active and selective Serum Amyloid A (SAA) inhibitor. Amilo-5MER TFA specifically inhibits the release of pro-inflammatory cytokines IL-6 and IL-1β from SAA-activated cells. Amilo-5MER TFA reduces chronic inflammation and relieves symptoms of diseases such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and multiple sclerosis (MS). Amilo-5MER TFA is promising for research of autoimmune diseases and chronic inflammatory diseases .
loading...
    loading...
Cat. No.: HY-P3502
CAS No.: 1841136-73-9
Synonyms: Ra101495; Ra3193
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

Zilucoplan (RA101495), a 15-amino acid macrocyclic peptide, is a potent complement component 5 (C5) inhibitor. Zilucoplan can be used in research of immune-mediated necrotising myopathy (IMNM) .
loading...
    loading...
Cat. No.: HY-150105
CAS No.: 2448172-22-1
Purity:  98.72%
Synonyms: BMF-219; Menin-MLL inhibitor 21
Icovamenib (BMF-219) is a selective, orally active, irreversible Menin inhibitor. Icovamenib forms a stable and irreversible covalent bond with Menin. Icovamenib promotes selective and controlled proliferation of beta cells and improvement of beta cell function in ex vivo human islet cultures. Icovamenib enhances glycemic control in animal diabetic models. Icovamenib induces a dose-dependent enhancement in insulin secretion potentiated by the GLP-1 RA. Icovamenib can be used for the study of multiple hematologic malignancies, solid tumors, and diabetes mellitus, such as diffuse large B-cell lymphoma (DLBCL), multiple myeloma (MM) and chronic lymphocytic leukemia and type 2 diabetes .
loading...
    loading...
Cat. No.: HY-P99259
CAS No.: 1613144-80-1
Synonyms: FPA 008; Anti-Human CSF1R Recombinant Antibody

Target:  

c-Fms

Research Areas:  

Inflammation/Immunology Cancer

Cabiralizumab (FPA 008) is an anti-CSF1R monoclonal antibody (MAb). Cabiralizumab enhances T cell infiltration and antitumor T cell immune responses. Cabiralizumab inhibits the activation of osteoclasts and blocks bone destruction, and can be used in the research of rheumatoid arthritis (RA). Cabiralizumab can combine with Nivolumab (HY-P9903) for lung cancer research .
loading...
    loading...
Cat. No.: HY-163102
CAS No.: 2271216-04-5
Target:  

TNF Receptor NF-κB

Research Areas:  

Inflammation/Immunology

IA-14069 is an orally active tumor necrosis factor-α (TNF-α) inhibitor. IA-14069 binds directly to TNF-α and TNF-α-triggered signaling (p-IκBα and NF-κB p65) activities. Additionally, IA-14069 exerts a suppressive effect on Dextran sodium sulfate (HY-116282C) (DSS)-induced colitis. IA-14069 can be used for the research of Rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) .
loading...
    loading...